What is Fortrea?
Fortrea is a clinical development and cro services company serving enterprise, public-sector, commercial, consumer, or regulated-market customers.
- Category
- Clinical development and CRO services
- Headquarters
- Durham, NC
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: FTRE
What is Fortrea?
Fortrea is a clinical development and cro services company headquartered in Durham, NC. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Fortrea is a clinical development and cro services company headquartered in Durham, NC. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Fortrea should be mapped as a scaled public-company account rather than an early-stage company. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Fortrea offer?
Fortrea's profile centers on Clinical operations, Patient access, Regulatory services, Data management.
- Clinical operations· Clinical development and CRO services
- Patient access· Clinical development and CRO services
- Regulatory services· Clinical development and CRO services
- Data management· Clinical development and CRO services
- Therapeutic development· Clinical development and CRO services
- Study startup· Clinical development and CRO services
How does Fortrea make money?
Fortrea makes money through commercial activity tied to clinical development and cro services.
Fortrea monetizes through the model common to clinical development and cro services: product sales, recurring services, subscriptions, contracts, distribution, transaction volume, underwriting, regulated utility revenue, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, uptime, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Fortrea?
Fortrea's named executives should be verified on the official leadership or investor-relations page before outreach.
- Fortrea executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Fortrea finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Fortrea operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Fortrea's leadership?
Fortrea should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.fortrea.comHow is Fortrea funded?
Fortrea's current status is Public company; Nasdaq: FTRE.
Fortrea's capital profile is best understood through its current public-company status: Public company; Nasdaq: FTRE. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capex plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Fortrea get here?
Fortrea's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingFortrea is foundedThe company begins building in clinical development and cro services.
- Scale-upCommercial footprint expandsFortrea broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: FTREPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Fortrea's competitors?
Fortrea competes with larger incumbents and focused specialists in clinical development and cro services.
- Thermo Fisher ScientificLife sciences tools, diagnostics, and services incumbent.
- DanaherLife sciences and diagnostics platform company.
- MedtronicGlobal medical technology competitor.
- PfizerLarge pharmaceutical company with global commercial reach.
- IQVIAHealthcare data and clinical research platform competitor.
Fortrea — frequently asked questions
